ID29574A - Formulasi 2-metil-tieno-benzodiazepin - Google Patents

Formulasi 2-metil-tieno-benzodiazepin

Info

Publication number
ID29574A
ID29574A IDW20010679A ID20010679A ID29574A ID 29574 A ID29574 A ID 29574A ID W20010679 A IDW20010679 A ID W20010679A ID 20010679 A ID20010679 A ID 20010679A ID 29574 A ID29574 A ID 29574A
Authority
ID
Indonesia
Prior art keywords
formulation
tieno
benzodiazepin
methyl
olanzapine
Prior art date
Application number
IDW20010679A
Other languages
English (en)
Indonesian (id)
Inventor
Charles Arthur Bunnell
Thomas Harry Ferguson
Barry Arnold Hendriksen
David Edward Tupper
Manuel Vicente Sanchez-Felix
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID29574A publication Critical patent/ID29574A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20010679A 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin ID29574A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
ID29574A true ID29574A (id) 2001-09-06

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010679A ID29574A (id) 1998-09-30 1999-03-24 Formulasi 2-metil-tieno-benzodiazepin

Country Status (28)

Country Link
EP (1) EP1119359B1 (ja)
JP (1) JP4551988B2 (ja)
CN (1) CN1146422C (ja)
AT (2) ATE267602T1 (ja)
AU (1) AU759751B2 (ja)
BR (1) BR9914156A (ja)
CA (1) CA2344873A1 (ja)
CZ (1) CZ302367B6 (ja)
DE (2) DE69917663T2 (ja)
DK (2) DK1119359T3 (ja)
EA (1) EA002580B1 (ja)
ES (2) ES2221376T3 (ja)
GE (1) GEP20094818B (ja)
HK (1) HK1041199B (ja)
HR (1) HRP20010238B1 (ja)
HU (1) HU227400B1 (ja)
ID (1) ID29574A (ja)
IL (2) IL141766A0 (ja)
MY (1) MY126476A (ja)
NO (1) NO328243B1 (ja)
NZ (1) NZ510208A (ja)
PL (1) PL196821B1 (ja)
PT (2) PT1119359E (ja)
SK (1) SK285944B6 (ja)
TR (1) TR200100885T2 (ja)
TW (1) TW577890B (ja)
UA (1) UA66872C2 (ja)
WO (1) WO2000018408A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
AU779452B2 (en) * 1999-12-28 2005-01-27 Cipla Limited New polymorphic forms of olanzapine
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
JP5324098B2 (ja) * 2004-11-16 2013-10-23 アルケルメス ファーマ アイルランド リミテッド 注射可能なナノ粒子のオランザピン製剤
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
US9469630B2 (en) 2010-10-18 2016-10-18 Sumitomo Dainippon Pharma Co., Ltd. Sustained-release formulation for injection
US9604995B2 (en) 2013-02-13 2017-03-28 Neuland Laboratories Limited Process for the preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
AU2018238136A1 (en) 2017-03-20 2019-11-07 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
DE69327542T2 (de) * 1992-11-17 2000-07-06 Yoshitomi Pharmaceutical Industries, Ltd. Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
ID21924A (id) * 1996-09-23 1999-08-12 Lilly Co Eli Olanzapin dihidrat d
US6169084B1 (en) * 1997-09-30 2001-01-02 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation

Also Published As

Publication number Publication date
NZ510208A (en) 2003-04-29
DE69917663T2 (de) 2005-05-25
JP4551988B2 (ja) 2010-09-29
EP1119359A1 (en) 2001-08-01
HRP20010238B1 (en) 2006-05-31
MY126476A (en) 2006-10-31
ATE267602T1 (de) 2004-06-15
HK1041199A1 (en) 2002-07-05
HUP0103636A3 (en) 2003-05-28
HK1041199B (zh) 2005-03-18
UA66872C2 (uk) 2004-06-15
ES2285294T3 (es) 2007-11-16
TR200100885T2 (tr) 2001-08-21
BR9914156A (pt) 2001-06-26
NO328243B1 (no) 2010-01-11
HRP20010238A2 (en) 2002-04-30
EA200100406A1 (ru) 2001-10-22
EP1119359A4 (en) 2001-12-19
TW577890B (en) 2004-03-01
NO20011583L (no) 2001-03-28
SK4162001A3 (en) 2002-03-05
DK1119359T3 (da) 2004-08-16
SK285944B6 (sk) 2007-11-02
HUP0103636A2 (hu) 2002-01-28
ES2221376T3 (es) 2004-12-16
EA002580B1 (ru) 2002-06-27
CA2344873A1 (en) 2000-04-06
CN1320038A (zh) 2001-10-31
PL196821B1 (pl) 2008-02-29
EP1119359B1 (en) 2004-05-26
IL141766A0 (en) 2002-03-10
DK1468689T3 (da) 2007-08-13
HU227400B1 (en) 2011-05-30
CZ302367B6 (cs) 2011-04-13
PL346981A1 (en) 2002-03-11
GEP20094818B (en) 2009-11-10
ATE359793T1 (de) 2007-05-15
CN1146422C (zh) 2004-04-21
AU3362799A (en) 2000-04-17
JP2002525330A (ja) 2002-08-13
DE69917663D1 (de) 2004-07-01
AU759751B2 (en) 2003-05-01
DE69935873D1 (de) 2007-05-31
PT1468689E (pt) 2007-07-09
CZ20011149A3 (cs) 2002-01-16
NO20011583D0 (no) 2001-03-28
IL141766A (en) 2006-12-31
DE69935873T2 (de) 2008-01-10
PT1119359E (pt) 2004-08-31
WO2000018408A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
ATE267602T1 (de) 2-methyl-thieno-benzodiazepin-formulierung
NO20010556L (no) Fremgangsmate for oftalmisk administrering
YU15499A (sh) Olanzapin dihidrat d
EA199900373A2 (ru) Фармацевтические композиции
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
YU15299A (sh) Farmaceutski sastavi
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
NL1006065A1 (nl) Inlegkruisje voor stringslip.
DK1073447T3 (da) N1-modificerede glycopeptider
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
ECSP982785A (es) Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion
ITMI981691A1 (it) Composizioni farmaceutiche atte alla sommistrazione per via transdermale di apomorfina
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide